(Q53008898)

10 May 2018

title

Enhanced immunisation and expression strategies using bacterial spores as heat-stable vaccine delivery vehicles. (English)

1 reference

10 May 2018

author name string

Nguyen Q Uyen

series ordinal

1

1 reference

10 May 2018

Huynh A Hong

series ordinal

2

1 reference

10 May 2018

Simon M Cutting

series ordinal

3

1 reference

10 May 2018

language of work or name

English

0 references

publication date

2 August 2006

1 reference

10 May 2018

published in

Vaccine

1 reference

10 May 2018

volume

25

1 reference

10 May 2018

issue

2

1 reference

10 May 2018

page(s)

356-365

1 reference

10 May 2018

Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

The use of bacterial spore formers as probiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

The intestinal life cycle of Bacillus subtilis and close relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Roles of Bacillus endospores in the environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Screening for bacillus isolates in the broiler gastrointestinal tract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Surface display of recombinant proteins on Bacillus subtilis spores.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Bacterial spores as vaccine vehicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Characterization of Bacillus probiotics available for human use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Bacillus probiotics: spore germination in the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Intracellular fate and immunogenicity of B. subtilis spores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Construction of a cloning site near one end of Tn917 into which foreign DNA may be inserted without affecting transposition in Bacillus subtilis or expression of the transposon-borne erm gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Genes encoding spore coat polypeptides from Bacillus subtilis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Plasmids for ectopic integration in Bacillus subtilis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Germination of the spore in the gastrointestinal tract provides a novel route for heterologous antigen delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Fate and dissemination of Bacillus subtilis spores in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Genes involved in formation of structured multicellular communities by Bacillus subtilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Fruiting body formation by Bacillus subtilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.07.025

1 reference

10 May 2018

1 reference

10 May 2018